Humana Inc. $HUM Shares Bought by Kingdon Capital Management L.L.C.

Kingdon Capital Management L.L.C. lifted its stake in Humana Inc. (NYSE:HUM) by 9.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 70,600 shares of the insurance provider’s stock after buying an additional 6,000 shares during the period. Humana makes up 2.3% of Kingdon Capital Management L.L.C.’s investment portfolio, making the stock its 8th largest holding. Kingdon Capital Management L.L.C. owned about 0.06% of Humana worth $18,368,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently bought and sold shares of the business. Gotham Asset Management LLC increased its position in shares of Humana by 35.9% in the third quarter. Gotham Asset Management LLC now owns 66,157 shares of the insurance provider’s stock valued at $17,212,000 after buying an additional 17,493 shares in the last quarter. Focus Partners Wealth lifted its stake in shares of Humana by 33.2% during the third quarter. Focus Partners Wealth now owns 6,368 shares of the insurance provider’s stock worth $1,662,000 after purchasing an additional 1,589 shares in the last quarter. Calydon Capital purchased a new position in shares of Humana in the third quarter valued at $1,651,000. Banco Bilbao Vizcaya Argentaria S.A. increased its position in shares of Humana by 248.7% during the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 15,624 shares of the insurance provider’s stock worth $4,065,000 after acquiring an additional 11,143 shares during the last quarter. Finally, California Public Employees Retirement System grew its position in shares of Humana by 6.2% during the third quarter. California Public Employees Retirement System now owns 231,441 shares of the insurance provider’s stock worth $60,214,000 after buying an additional 13,566 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Up 1.0%

HUM opened at $165.38 on Monday. The firm’s 50-day simple moving average is $212.90 and its 200-day simple moving average is $247.52. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.00 and a current ratio of 2.00. Humana Inc. has a twelve month low of $163.60 and a twelve month high of $315.35. The firm has a market cap of $19.85 billion, a price-to-earnings ratio of 16.84, a PEG ratio of 1.77 and a beta of 0.44.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping the consensus estimate of ($4.01) by $0.05. The firm had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company’s quarterly revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the firm earned ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 annualized dividend and a yield of 2.1%. Humana’s dividend payout ratio is 36.05%.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Sanford C. Bernstein reiterated an “outperform” rating and set a $344.00 price target on shares of Humana in a research report on Tuesday, January 6th. Royal Bank Of Canada downgraded Humana from an “outperform” rating to a “sector perform” rating and lowered their price target for the company from $322.00 to $189.00 in a report on Thursday, February 12th. Jefferies Financial Group dropped their target price on Humana from $310.00 to $235.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. KeyCorp reissued a “sector weight” rating on shares of Humana in a research note on Friday, December 12th. Finally, Barclays lowered their price target on Humana from $245.00 to $176.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 24th. Seven investment analysts have rated the stock with a Buy rating, sixteen have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $225.48.

Insider Transactions at Humana

In related news, insider Sanjay K. Shetty acquired 810 shares of the firm’s stock in a transaction on Monday, February 23rd. The shares were purchased at an average price of $185.21 per share, with a total value of $150,020.10. Following the acquisition, the insider directly owned 11,657 shares in the company, valued at $2,158,992.97. The trade was a 7.47% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.20% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.